Hennion & Walsh Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Buy |
94,841
+17,231
| +22% | +$543K | 0.12% | 222 |
|
|
2025
Q1 | $2.54M | Buy |
77,610
+11,304
| +17% | +$370K | 0.11% | 226 |
|
|
2024
Q4 | $2.4M | Buy |
66,306
+25,004
| +61% | +$904K | 0.11% | 245 |
|
|
2024
Q3 | $1.29M | Sell |
41,302
-1,147
| -3% | -$35.8K | 0.06% | 395 |
|
|
2024
Q2 | $1.14M | Buy |
42,449
+2,605
| +7% | +$69.7K | 0.06% | 392 |
|
|
2024
Q1 | $1.36M | Buy |
39,844
+16,605
| +71% | +$566K | 0.07% | 343 |
|
|
2023
Q4 | $673K | Buy |
+23,239
| New | +$673K | 0.04% | 496 |
|
|
2022
Q4 | – | Sell |
-121,835
| Closed | -$4.12M | – | 806 |
|
|
2022
Q3 | $4.12M | Sell |
121,835
-6,883
| -5% | -$233K | 0.27% | 89 |
|
|
2022
Q2 | $3.72M | Sell |
128,718
-73,964
| -36% | -$2.14M | 0.23% | 117 |
|
|
2022
Q1 | $6.55M | Sell |
202,682
-14,360
| -7% | -$464K | 0.35% | 71 |
|
|
2021
Q4 | $6.33M | Sell |
217,042
-27,980
| -11% | -$816K | 0.31% | 88 |
|
|
2021
Q3 | $6.54M | Sell |
245,022
-7,946
| -3% | -$212K | 0.34% | 67 |
|
|
2021
Q2 | $7.79M | Buy |
252,968
+1,364
| +0.5% | +$42K | 0.42% | 49 |
|
|
2021
Q1 | $6.59M | Buy |
+251,604
| New | +$6.59M | 0.4% | 56 |
|